Reaction
Bone Cancer Metastatic reporting signals
As of the last recalculation, Bone Cancer Metastatic appears in 521 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is FULVESTRANT (PRR 41.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fulvestrant | 32 | 41.2 | 41.2 |
| Ado-Trastuzumab Emtansine | 7 | 33.6 | 33.6 |
| Leuprolide Acetate | 36 | 19.8 | 19.9 |
| Abiraterone | 6 | 17.8 | 17.8 |
| Lapatinib | 6 | 15.6 | 15.6 |
| Abiraterone Acetate | 14 | 13.9 | 13.9 |
| Lutetium Lu 177 Vipivotide Tetraxetan | 4 | 12.2 | 12.2 |
| Enzalutamide | 15 | 10.5 | 10.5 |
| Ranitidine Hydrochloride | 13 | 9.8 | 9.8 |